The Association between Placenta Accreta Spectrum Severity and Incidence of Small for Gestational Age Neonates

Abstract

Objective The aim of the study is to evaluate whether pathologic severity of placenta accreta spectrum (PAS) is correlated with the incidence of small for gestational age (SGA) and neonatal birthweight.

Study Design This was a multicenter cohort study of viable, non-anomalous, singleton gestations delivered with histology-proven PAS. Data including maternal history, neonatal birthweight, and placental pathology were collected and deidentified. Pathology was defined as accreta, increta, or percreta. The primary outcome was rate of SGA defined by birth weight less than the 10th percentile. The secondary outcomes included incidence of large for gestational age (LGA) babies as defined by birth weight greater than the 90th percentile as well as incidence of SGA and LGA in preterm and term gestations. Statistical analysis was performed using Chi-square, Kruskal–Wallis, and log-binomial regression. Increta and percreta patients were each compared with accreta patients.

Results Among the cohort of 1,008 women from seven United States centers, 865 subjects were included in the analysis. The relative risk (RR) of SGA for increta and percreta did not differ from accreta after adjusting for confounders (adjusted RR = 0.63, 95% confidence interval [CI]: 0.36–1.10 for increta and aRR = 0.72, 95% CI: 0.45–1.16 for percreta). The results were stratified by placenta previa status, which did not affect results. There was no difference in incidence of LGA (p = 1.0) by PAS pathologic severity. The incidence of SGA for all PAS patients was 9.2% for those delivered preterm and 18.7% for those delivered at term (p = 0.004). The incidence of LGA for all PAS patients was 12.6% for those delivered preterm and 13.2% for those delivered at term (p = 0.8203).

Conclusion There was no difference in incidence of SGA or LGA when comparing accreta to increta or percreta patients regardless of previa status. Although we cannot suggest causation, our results suggest that PAS, regardless of pathologic severity, is not associated with pathologic fetal growth in the preterm period.

Key Points

• PAS severity is not associated with SGA in the preterm period.

• PAS severity is not associated with LGA.

• Placenta previa does not affect the incidence of SGA in women with PAS.

Keywords

placenta accreta spectrum - birth weight - small for gestational age

• References

• 1 Moeini R, Dalili H, Kavyani Z. et al. Maternal and neonatal outcomes of abnormal placentation: a case-control study. J Matern Fetal Neonatal Med 2021; 34 (19) 3097-3103
• 2 ACOG. ACOG Practice Bulletin No. 204 summary: fetal growth restriction. Obstet Gynecol 2019; 133 (02) 390-392
• 3 Einerson BD, Comstock J, Silver RM, Branch DW, Woodward PJ, Kennedy A. Placenta accreta spectrum disorder: uterine dehiscence, not placental invasion. Obstet Gynecol 2020; 135 (05) 1104-1111
• 4 Harper LM, Odibo AO, Macones GA, Crane JP, Cahill AG. Effect of placenta previa on fetal growth. Am J Obstet Gynecol 2010; 203 (04) 330.e1-330.e5
• 5 Jauniaux E, Dimitrova I, Kenyon N. et al. Impact of placenta previa with placenta accreta spectrum disorder on fetal growth. Ultrasound Obstet Gynecol 2019; 54 (05) 643-649
• 6 Silver RM, Branch DW. Placenta accreta spectrum. N Engl J Med 2018; 378 (16) 1529-1536
• 7 Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet 2019; 146 (01) 20-24
• 8 Duryea EL, Hawkins JS, McIntire DD, Casey BM, Leveno KJ. A revised birth weight reference for the United States. Obstet Gynecol 2014; 124 (01) 16-22
• 9 Organization WH. Preterm birth. Published 2018. Accessed March 22, 2022 at: https://www.who.int/news-room/fact-sheets/detail/preterm-birth 2022
• 10 Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol 2018; 218 (01) 75-87
• 11 Baldwin HJ, Patterson JA, Nippita TA. et al. Maternal and neonatal outcomes following abnormally invasive placenta: a population-based record linkage study. Acta Obstet Gynecol Scand 2017; 96 (11) 1373-1381
• 12 Hecht JL, Baergen R, Ernst LM. et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. Mod Pathol 2020; 33 (12) 2382-2396
• 13 Aalipour S, Salmanian B, Fox KA. et al. Placenta accreta spectrum: correlation between FIGO clinical classification and histopathologic findings. Am J Perinatol 2021; (e-pub ahead of print)